Akari Therapeutics Plc - ADR

XNAS:AKTX   3:59:40 PM EDT
0.82
+0.10 (+13.10%)
7:59:48 PM EDT: $0.62 -0.20 (-23.89%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Akari Therapeutics Plc - ADR Stock, XNAS:AKTX

22 Boston Wharf Road, 7th Floor, Boston, Massachusetts 02210
United States of America
Phone: +1.929.274.7510
Number of Employees:
http://www.akaritx.com

Description

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Boston, MA.